Form 4: Sangamo Therapeutics VP Amy Pooler Reports Stock Transactions for Tax Withholding

Sentiment:

SEC Form 4


Amy Pooler, VP and Head of Research at Sangamo Therapeutics, reports disposition of shares to cover tax obligations related to vesting Restricted Stock Units (RSUs).

Summary

  • Amy Pooler, VP and Head of Research at Sangamo Therapeutics, filed a Form 4 detailing changes in beneficial ownership of company stock.
  • The reported transactions involve the disposition of common stock to cover tax withholding obligations related to the vesting of RSU grants.
  • On February 24, 2024, 2,209 shares were disposed of at a price of $1.13 per share for tax purposes.
  • On February 25, 2024, 2,459 shares were disposed of at a price of $1.13 per share for tax purposes.
  • Following these transactions, Pooler directly owns 196,314 shares of Sangamo Therapeutics common stock.
  • The dispositions were not discretionary trades but were mandated by tax withholding requirements under the company's 2018 Equity Incentive Plan.
  • The vesting of Pooler's RSU grants is contingent upon continuous service with Sangamo Therapeutics.

Sentiment

Score: 5

Explanation: The document is a routine regulatory filing, and the transactions are related to tax obligations, indicating a neutral sentiment.

Future Outlook

The remaining RSU shares will continue to vest in future quarterly installments, contingent upon the Reporting Person's continuous service.

Industry Context

Form 4 filings are standard practice for reporting changes in beneficial ownership by company insiders, providing transparency to investors.

Stakeholder Impact

  • The transactions have a minimal impact on shareholders as they are related to tax withholding and do not represent a change in the company's fundamentals.

Key Dates

DateDescription
02/25/2021Date of RSU grant that will vest in one final installment on February 25, 2024.
02/25/2022Date of RSU grant that will vest in successive equal quarterly installments through February 25, 2025.
02/24/2023Date of RSU grant that will vest as to one-quarter (1/4) of the shares on the first anniversary of the grant date, and the remainder of the shares will vest in 8 successive equal quarterly installments thereafter.
01/22/2024Date of RSU grant that will vest as to one-half (1/2) of the shares on the first anniversary of the grant date, and the remainder of the shares will vest in 4 successive equal quarterly installments thereafter.
02/23/2024Issuer's closing stock price of $1.13/share used for tax withholding purposes.
02/24/2024Date of transaction where 2,209 shares were disposed of for tax withholding.
02/25/2024Date of transaction where 2,459 shares were disposed of for tax withholding.
02/27/2024Date of signature on the Form 4 filing.

Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.